Rheumatology — a weekly podcast briefing of the most significant peer-reviewed rheumatology literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.
Editor's Pick: Rituximab vs Azathioprine for Eosinophilic Granulomatosis With Polyangiitis Maintenance Therapy: A Randomized Clinical Trial (JAMA, 2026)
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.
Welcome to This Week in Rheumatology. This week we're covering 10 notable papers spanning B-cell targeted therapy in two difficult systemic diseases, interstitial lung disease across the connective tissue diseases, and real-world comparisons of targe…
This week's papers:
1. Ianalumab for the Treatment of Patients with Sjögren's Disease. — New England Journal of Medicine 2026
2. Rituximab vs Azathioprine for Eosinophilic Granulomatosis With Polyangiitis Maintenance Therapy: A Randomized Clinical Trial. — JAMA 2026
3. Real-world association of biologic and targeted synthetic DMARD use with mortality in rheumatoid arthritis-associated interstitial lung disease: a nationwide c… — RMD Open 2026
4. Survival and immunomodulatory therapy in autoimmune disease-associated progressive pulmonary fibrosis: a multicenter registry (NEREA). — Rheumatology 2026
5. Predictors of response and long-term efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study. — Seminars in Arthritis and Rheumatism 2026
6. Comparative effectiveness and safety of five Janus kinase inhibitors in real-world clinical practice: the multicentre ANSWER cohort. — Rheumatology 2026
7. Real‑world assessment of the effectiveness and response profiles of biologic DMARDs in psoriatic arthritis: findings from an emulated multicentre clinical tria… — Annals of the Rheumatic Diseases 2026
8. International recommendations for the use of imaging in the diagnosis and assessment of polymyalgia rheumatica. — Annals of the Rheumatic Diseases 2026
9. Extra-renal disease patterns in lupus nephritis: clinical and serological activity confers increased risk of renal flares and damage accrual. — Rheumatology 2026
10. First trimester exposure to hydroxychloroquine during pregnancy and major congenital malformations: a systematic review and meta-analysis. — RMD Open 2026
Listen at https://audioscholar.cc/episode/c5a7y5e3ff
22 Oct 2026
This Week in Rheumatology — Oct 22, 2026
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.
Welcome to This Week in Rheumatology. This week we're covering 10 notable papers spanning long-term strategy and…
This week's papers:
1. Ten-year outcomes after treat-to-target therapy in early rheumatoid arthritis. — Annals of the Rheumatic Diseases 2026
2. Cardiovascular risk associated with first-line Janus kinase inhibitors versus TNF inhibitors in patients with RA: a nationwide cohort study. — Rheumatology 2026
3. Reasons-stratified treatment retention after JAK inhibitor discontinuation in rheumatoid arthritis: the ANSWER cohort study. — Rheumatology 2026
4. Innovative therapies in rheumatoid arthritis: CAR T cells and bispecific antibodies. — Lancet Rheumatology 2026
5. Sustained Inhibition of Structural Damage Progression and Improvements in Disease Activity With Guselkumab in Biologic-Naïve Participants with Active and Erosi… — Arthritis & Rheumatology 2026
6. The ASAS core set for the assessment of axial spondyloarthritis in clinical practice. — Annals of the Rheumatic Diseases 2026
7. Emerging therapies for knee osteoarthritis. — Nature Reviews Rheumatology 2026
8. Deep clinical renal response in lupus nephritis treated with belimumab: a real-world cohort study. — Rheumatology 2026
9. Initial treatment strategies and outcomes across haemodynamic thresholds and risk stratification in incident systemic sclerosis-associated pulmonary arterial h… — Arthritis & Rheumatology 2026
10. Clinical performance of obstetric antiphospholipid syndrome classification criteria: an ambispective cohort study. — Rheumatology 2026
Listen at https://audioscholar.cc/episode/4wc7uuj3d9
15 Oct 2026
This Week in Rheumatology — Oct 15, 2026
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.
Welcome to This Week in Rheumatology. This week we're covering 10 notable papers spanning a refreshed approach to…
This week's papers:
1. The 2026 British Society for Rheumatology guideline for the treatment of polymyalgia rheumatica. — Rheumatology 2026
2. Imaging for diagnosis, monitoring and outcome prediction in polymyalgia rheumatica: a systematic literature review and meta-analysis informing an international… — RMD Open 2026
3. Long-term comparative outcomes of rituximab and belimumab in lupus patients. — Rheumatology 2026
4. B-cell landscape remodelling following dual BAFF/APRIL inhibition with telitacicept in lupus nephritis: extrafollicular axis clearance and its association with… — Lupus Science & Medicine 2026
5. Antimalarial exposure and renal histopathologic findings in lupus nephritis. — Rheumatology 2026
6. Bimekizumab efficacy across GRAPPA domains to 3 years in patients with psoriatic arthritis: a post hoc analysis of two phase 3 studies. — Rheumatology 2026
7. Higher risk of Long COVID among patients with autoimmune rheumatic diseases and immunomodulatory therapy: a retrospective cohort analysis of national US data. — Arthritis & Rheumatology 2026
8. Cardiovascular risk stratification using chest CT in idiopathic inflammatory myopathies. — Rheumatology 2026
9. IgG4-related disease is not associated with an increased incidence of malignancy in a large, single-centre cohort. — Annals of the Rheumatic Diseases 2026
10. Genomic ascertainment of systemic autoinflammatory diseases: a retrospective cohort study in two population-based biobanks. — Lancet Rheumatology 2026
Listen at https://audioscholar.cc/episode/yj7dmq7nf3
Contact AudioScholar Rheumatology Weekly
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of AudioScholar Rheumatology Weekly?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
